{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:49Z","timestamp":1792788169866,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2025YFC270840"],"award-info":[{"award-number":["2025YFC270840"]}]},{"name":"Peking University People\u2019s Hospital Horizontal Scientific Research Topics","award":["2025-h11"],"award-info":[{"award-number":["2025-h11"]}],"id":[{"id":"https:\/\/ror.org\/035adwg89","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-026-02201-1","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:33:23Z","timestamp":1783650803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preliminary study on PAX1\/JAM3 methylation and HPV viral load in CIN3-like squamous cell carcinoma: Are there differences from CIN3 and early invasive carcinoma?"],"prefix":"10.1186","volume":"18","author":[{"given":"Mingzhu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"2201_CR1","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1093\/annonc\/mdr015","volume":"22","author":"M Arbyn","year":"2008","unstructured":"Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2008;22:2675\u201386.","journal-title":"Ann Oncol"},{"key":"2201_CR2","unstructured":"World Health Organization. Female genital tumours. IARC press. WHO classification of tumours. 5th Edition Volume 4[EB\/ OL]. (2020-09-09)[2021-01-25]. https: \/\/tumourclassification. iarc.who.int\/9789283245049."},{"key":"2201_CR3","doi-asserted-by":"publisher","first-page":"e000205","DOI":"10.1136\/gocm-2025-000205","volume":"5","author":"M Li","year":"2025","unstructured":"Li M, Li J, Li X, et al. Guidelines for cervical cancer screening in China part II. Gynecol Obstet Clin Med. 2025;5:e000205.","journal-title":"Gynecol Obstet Clin Med"},{"key":"2201_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1046\/j.1525-1438.2000.00017.x","volume":"10","author":"AI Al-Nafussi","year":"2000","unstructured":"Al-Nafussi AI, Monaghan H. Squamous carcinoma of the uterine cervix with CIN 3-like growth pattern: an under-diagnosed lesion. Int J Gynecol Cancer. 2000;10:95\u20139.","journal-title":"Int J Gynecol Cancer"},{"key":"2201_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/PGP.0000000000000383","volume":"37","author":"CJR Stewart","year":"2018","unstructured":"Stewart CJR, Crook ML. Podoplanin and SOX2 expression in CIN 3-like squamous cell carcinoma of the cervix. Int J Gynecol Pathol. 2018;37:59\u201367.","journal-title":"Int J Gynecol Pathol"},{"key":"2201_CR6","doi-asserted-by":"publisher","first-page":"1354838","DOI":"10.3389\/fonc.2024.1354838","volume":"14","author":"Z Xing","year":"2024","unstructured":"Xing Z, Danhua S, Xiaobo Z. Diagnostic validity of p16, E-cadherin, cyclin D1, p53, and HPV E6\/E7 mRNA in CIN 3-like squamous cell carcinoma of the cervix. Front Oncol. 2024;14:1354838.","journal-title":"Front Oncol"},{"key":"2201_CR7","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1002\/mgg3.506","volume":"7","author":"C Fang","year":"2019","unstructured":"Fang C, Wang S, Liou Y, Chen M, Ouyang W, Duan K. The promising role of PAX1 (aliases: HUP48, OFC2) gene methylation in cancer screening. Mol Genet Genom Med. 2019;7:e506.","journal-title":"Mol Genet Genom Med"},{"key":"2201_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12094-020-02416-5","volume":"23","author":"H Liang","year":"2021","unstructured":"Liang H, Li GL, Liu J, Fu M, Huang H, Zhao K, et al. The application value of PAX1 and ZNF582 gene methylation in high grade intraepithelial lesion and cervical cancer. Clin Transl Oncol. 2021;23:283\u20138.","journal-title":"Clin Transl Oncol"},{"key":"2201_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12010063","author":"M Li","year":"2022","unstructured":"Li M, Zhao C, Zhao Y, Li J, Zhang X, Zhang W, et al. Association and effectiveness of PAX1 methylation and HPV viral load for the detection of cervical high-grade squamous intraepithelial lesion. Pathogens. 2022. https:\/\/doi.org\/10.3390\/pathogens12010063.","journal-title":"Pathogens"},{"key":"2201_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13148-020-00885-7","volume":"12","author":"L Kong","year":"2020","unstructured":"Kong L, Wang L, Wang Z, Xiao X, You Y, Wu H, et al. DNA methylation for cervical cancer screening: a training set in China. Clin Epigenetics. 2020;12:91.","journal-title":"Clin Epigenetics"},{"key":"2201_CR11","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/bjc.2014.392","volume":"111","author":"A Boers","year":"2014","unstructured":"Boers A, Bosgraaf RP, van Leeuwen RW, Schuuring E, Heideman DAM, Massuger LFAG, et al. DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women. Br J Cancer. 2014;111:1095\u2013101.","journal-title":"Br J Cancer"},{"key":"2201_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071430","author":"M Li","year":"2024","unstructured":"Li M, Zhao C, Zhang X, Li J, Zhao Y, Zhang W, et al. PAX1\/JAM3 methylation and HPV viral load in women with persistent HPV infection. Cancers. 2024. https:\/\/doi.org\/10.3390\/cancers16071430.","journal-title":"Cancers"},{"key":"2201_CR13","unstructured":"Food and Drug Administration. New Approaches in the evaluation for high-risk human papillomavirus nucleic acid detection devices[EB\/OL]. [2019\u201303\u201308].https:\/\/www.fda.gov\/media\/122799\/download.."},{"key":"2201_CR14","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.2214\/AJR.19.21819","volume":"214","author":"M Saleh","year":"2018","unstructured":"Saleh M, Virarkar M, Javadi S, Elsherif SB, de Castro Faria S, Bhosale P. Cervical cancer: 2018 revised International Federation of Gynecology and Obstetrics staging system and the role of imaging. AJR Am J Roentgenol. 2018;214:1182\u201395.","journal-title":"AJR Am J Roentgenol"},{"key":"2201_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.mpdhp.2010.12.003","volume":"17","author":"J Wilkens","year":"2011","unstructured":"Wilkens J, Beattie G, Al-Nafussi A. Metastatic CIN3-like squamous carcinoma. Diagn Histopathol. 2011;17:140\u20133.","journal-title":"Diagn Histopathol"},{"key":"2201_CR16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/14789450.2021.1980387","volume":"18","author":"C Guzel","year":"2021","unstructured":"Guzel C, van Sten-Van\u2019T HJ, de Kok IMCM, Govorukhina NI, Boychenko A, Luider TM, et al. Molecular markers for cervical cancer screening. Expert Rev Proteomic. 2021;18:675\u201391.","journal-title":"Expert Rev Proteomic"},{"key":"2201_CR17","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1111\/jog.14869","volume":"47","author":"B Li","year":"2021","unstructured":"Li B, Guo R, Lai T, Qiao L, Fu H. The application of PAX1 methylation detection and HPV E6\/E7 mRNA detection in cervical cancer screening. J Obstet Gynaecol Res. 2021;47:2720\u20138.","journal-title":"J Obstet Gynaecol Res"},{"key":"2201_CR18","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1136\/ijgc-2019-001144","volume":"30","author":"H Liu","year":"2020","unstructured":"Liu H, Meng X, Wang J. Real time quantitative methylation detection of PAX1 gene in cervical cancer screening. Int J Gynecol Cancer. 2020;30:1488\u201392.","journal-title":"Int J Gynecol Cancer"},{"key":"2201_CR19","first-page":"1674","volume":"8","author":"J Xu","year":"2015","unstructured":"Xu J, Xu L, Yang B, Wang L, Lin X, Tu H. Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer. Int J Clin Exp Patho. 2015;8:1674\u201381.","journal-title":"Int J Clin Exp Patho"},{"key":"2201_CR20","doi-asserted-by":"publisher","first-page":"44373","DOI":"10.18632\/oncotarget.6250","volume":"6","author":"A Yin","year":"2015","unstructured":"Yin A, Zhang Q, Kong X, Jia L, Yang Z, Meng L, et al. JAM3 methylation status as a biomarker for diagnosis of preneoplastic and neoplastic lesions of the cervix. Oncotarget. 2015;6:44373\u201387.","journal-title":"Oncotarget"},{"key":"2201_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13148-016-0196-3","volume":"8","author":"A Boers","year":"2016","unstructured":"Boers A, Wang R, van Leeuwen RW, Klip HG, de Bock GH, Hollema H, et al. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2\/3. Clin Epigenetics. 2016;8:29.","journal-title":"Clin Epigenetics"},{"key":"2201_CR22","doi-asserted-by":"publisher","first-page":"1181982","DOI":"10.3389\/fonc.2023.1181982","volume":"13","author":"L Kong","year":"2023","unstructured":"Kong L, Wang L, Wang Z, Xiao X, You Y, Wu H, et al. Cytological DNA methylation for cervical cancer screening: a validation set. Front Oncol. 2023;13:1181982.","journal-title":"Front Oncol"},{"key":"2201_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ygyno.2017.11.016","volume":"148","author":"L Dong","year":"2018","unstructured":"Dong L, Wang MZ, Zhao X, Feng R, Hu S, Zhang Q, et al. Human papillomavirus viral load as a useful triage tool for non-16\/18 high-risk human papillomavirus positive women: A prospective screening cohort study. Gynecol Oncol. 2018;148:103\u201310.","journal-title":"Gynecol Oncol"},{"key":"2201_CR24","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.7150\/jca.57460","volume":"12","author":"X Li","year":"2021","unstructured":"Li X, Zhou X, Zeng M, Zhou Y, Zhang Y, Liou Y, et al. Methylation of PAX1 gene promoter in the prediction of concurrent chemo-radiotherapy efficacy in cervical cancer. J Cancer. 2021;12:5136\u201343.","journal-title":"J Cancer"},{"key":"2201_CR25","doi-asserted-by":"publisher","first-page":"9195","DOI":"10.1038\/s41598-019-45477-5","volume":"9","author":"P Su","year":"2019","unstructured":"Su P, Lai H, Huang R, Chen L, Wang Y, Wu T, et al. Paired Box-1 (PAX1) Activates Multiple Phosphatases and Inhibits Kinase Cascades in Cervical Cancer. Sci Rep-UK. 2019;9:9195.","journal-title":"Sci Rep-UK"},{"key":"2201_CR26","first-page":"1043","volume":"39","author":"Y Gu","year":"2024","unstructured":"Gu Y, Chu C, Yuan B, Wang J, Pan S. Expression and hypermethylation of JAM and EPB41L3 in cervical squamous cell carcinoma: Clinical significance and applications. Histol Histopathol. 2024;39:1043\u201351.","journal-title":"Histol Histopathol"},{"key":"2201_CR27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ygyno.2005.12.029","volume":"102","author":"CS Nagi","year":"2006","unstructured":"Nagi CS, Schlosshauer PW. Endocervical glandular involvement is associated with high-grade SIL. Gynecol Oncol. 2006;102:240\u20133.","journal-title":"Gynecol Oncol"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02201-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02201-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02201-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:13:31Z","timestamp":1791155611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-026-02201-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2201"],"URL":"https:\/\/doi.org\/10.1186\/s13148-026-02201-1","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Peking University People\u2019s Hospital (IRB number:2025PHB437-001, date of IRB approval: 29 September 2025.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patients to publish this paper.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"178"}}